Estadísticas de Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials

Visitas totales

views
Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials 0

Visitas totales por mes

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0

Visitas de archivo

views
Meza_Angi2021.pdf 9